Analyst Sees 'Broadening Rally' In Semiconductors In 2025: 2 Top Stock Picks, 2 To Avoid
A semiconductor analyst sees a continued focus on AI growth for the sector in 2025 and highlights some winners and stocks to ...
2JD Vance Says Violent Jan. 6 Rioters 'Shouldn't Be Pardoned,
Jake Lang, who is awaiting trial on Jan. 6 charges, addressed JD Vance: 'J6 families have been CRUSHED by mixed messaging.' ...
Looking For Bitcoin Exposure With Downside Protection? There's Now An ETF For That (CORRECTED)
This story has been updated to correct a reference to the stock ticker for an upcoming Calamos 100% downside-protected ...
An Interviewer Asked To See How Much Money Warren Buffett Carried In His Wallet And His Answer Is Just What You'd Expect From Him
Buffett has a remarkably traditional approach to money for someone who has influenced modern investing. He stated that he ...
Goldman Sachs Restructures Business for Financing Growth
Goldman Sachs Inc. (NYSE: GS) is reorganizing its structure to focus on financing, reflecting its ambition to be a leader in ...
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking ...
What's Going On With United States Steel Shares Monday?
United States Steel Corp. (NYSE:X) stock is trading higher Monday following a report that Cleveland-Cliffs Inc. (NYSE:CLF) will partner with Nucor Corp. (NYSE:NUE) to make a potential bid to acquire ...
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Buying $1000 In RJF: If an investor had bought $1000 of RJF stock 10 years ago, it would be worth $4,440.23 today based on a ...
Expert Outlook: Lazard Through The Eyes Of 5 Analysts
In the assessment of 12-month price targets, analysts unveil insights for Lazard, presenting an average target of $59.2, a high estimate of $65.00, and a low estimate of $52.00. This current average ...
Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?
Shares of Intra-Cellular Therapies Inc. (NASDAQ: ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company.
Broadcom's $3 Billion Bet: Balancing Market Signals, AI-Driven Growth
Broadcom's recent fiscal performance underscores its resilience, with AI-related revenue driving better-than-expected ...
6CRWD : Decoding CrowdStrike Holdings's Options Activity...
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 40% bearish. Among these notable ...